Insufficient scRNA-seq data for expression of CEACAM8 at single-cell level.
Insufficient scRNA-seq data for expression of CEACAM8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 98% | 636.54 | 236 / 241 | 0% | 0 | 0 / 0 |
lung | 90% | 173.74 | 523 / 578 | 7% | 0.37 | 81 / 1155 |
peripheral blood | 81% | 2617.21 | 756 / 929 | 0% | 0 | 0 / 0 |
intestine | 26% | 13.11 | 247 / 966 | 14% | 0.44 | 73 / 527 |
adipose | 38% | 10.09 | 455 / 1204 | 0% | 0 | 0 / 0 |
liver | 35% | 13.35 | 79 / 226 | 0% | 0 | 0 / 406 |
breast | 29% | 7.49 | 135 / 459 | 0% | 0.01 | 4 / 1118 |
heart | 25% | 7.90 | 217 / 861 | 0% | 0 | 0 / 0 |
thymus | 23% | 5.46 | 151 / 653 | 2% | 0.05 | 12 / 605 |
kidney | 21% | 3.31 | 19 / 89 | 1% | 0.01 | 7 / 901 |
stomach | 4% | 1.72 | 16 / 359 | 13% | 0.35 | 37 / 286 |
brain | 16% | 2.93 | 425 / 2642 | 0% | 0.01 | 1 / 705 |
bladder | 10% | 1.10 | 2 / 21 | 4% | 0.25 | 21 / 504 |
esophagus | 7% | 1.49 | 103 / 1445 | 5% | 0.08 | 10 / 183 |
blood vessel | 11% | 2.72 | 148 / 1335 | 0% | 0 | 0 / 0 |
muscle | 10% | 1.76 | 79 / 803 | 0% | 0 | 0 / 0 |
uterus | 8% | 1.34 | 14 / 170 | 0% | 0.00 | 1 / 459 |
pancreas | 2% | 0.49 | 8 / 328 | 6% | 0.23 | 10 / 178 |
adrenal gland | 7% | 0.94 | 17 / 258 | 1% | 0.01 | 2 / 230 |
ovary | 4% | 0.61 | 7 / 180 | 0% | 0.01 | 2 / 430 |
prostate | 3% | 0.53 | 7 / 245 | 0% | 0.00 | 1 / 502 |
skin | 2% | 0.27 | 38 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0007157 | Biological process | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0098552 | Cellular component | side of membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CEACAM8 |
Protein name | CEA cell adhesion molecule 8 Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b) Carcinoembryonic antigen-related cell adhesion molecule 8 (cDNA, FLJ93041, Homo sapiens carcinoembryonic antigen-related cell adhesionmolecule 8 (CEACAM8), mRNA) |
Synonyms | hCG_21882 CGM6 |
Description | FUNCTION: Cell surface glycoprotein that plays a role in cell adhesion in a calcium-independent manner . Mediates heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 . Heterophilic interaction with CEACAM8 occurs in activated neutrophils . . |
Accessions | M0R1X3 ENST00000244336.10 ENST00000599005.1 Q0Z7S6 P31997 |